U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Alopecia areata 1(AA1)

MedGen UID:
400208
Concept ID:
C1863094
Disease or Syndrome
Synonym: AA1
 
Monarch Initiative: MONDO:0007082
OMIM®: 104000

Definition

Alopecia areata is a genetically determined, immune-mediated disorder of the hair follicle with an estimated lifetime risk of approximately 2%, making it one of the most common human autoimmune diseases. It shows a spectrum of severity that ranges from patchy localized hair loss on the scalp to the complete absence of hair everywhere on the body (Gilhar and Kalish, 2006). [from OMIM]

Clinical features

From HPO
Autoimmunity
MedGen UID:
2136
Concept ID:
C0004368
Pathologic Function
The occurrence of an immune reaction against the organism's own cells or tissues.
Nail pits
MedGen UID:
57463
Concept ID:
C0150993
Finding
Small (typically about 1 mm or less in size) depressions on the dorsal nail surface.
Alopecia totalis
MedGen UID:
75525
Concept ID:
C0263504
Disease or Syndrome
Loss of all scalp hair.
Alopecia universalis
MedGen UID:
120481
Concept ID:
C0263505
Disease or Syndrome
Alopecia areata is a common disorder that causes hair loss. "Alopecia" is a Latin term that means baldness, and "areata" refers to the patchy nature of the hair loss that is typically seen with this condition.\n\nIn most people with alopecia areata, hair falls out in small, round patches, leaving coin-sized areas of bare skin. This patchy hair loss occurs most often on the scalp but can affect other parts of the body as well. Uncommonly, the hair loss involves the entire scalp (in which case the condition is known as alopecia totalis) or the whole body (alopecia universalis). Other rare forms of alopecia areata, which have different patterns of hair loss, have also been reported.\n\nAlopecia areata affects people of all ages, although it most commonly appears in adolescence or early adulthood. Hair loss occurs over a period of weeks. The hair usually grows back after several months, although it may fall out again. In some cases, unpredictable cycles of hair loss followed by regrowth can last for years. In addition to hair loss, some affected individuals have fingernail and toenail abnormalities, such as pits on the surface of the nails.\n\nThe hair loss associated with alopecia areata is not painful or disabling. However, it causes changes in a person's appearance that can profoundly affect quality of life and self-esteem. In some people, the condition can lead to depression, anxiety, and other emotional or psychological issues.
Trachyonychia
MedGen UID:
107484
Concept ID:
C0546956
Disease or Syndrome
Excessive longitudinal ridging that gives the surface of the nail plate a rough appearance. It results from multiple foci of defective keratinization of the proximal nail matrix.
Patchy alopecia
MedGen UID:
350774
Concept ID:
C1862862
Finding
Transient, non-scarring hair loss and preservation of the hair follicle located in in well-defined patches.

Recent clinical studies

Etiology

Doytcheva K, Tan T, Guitart J, Gerami P, Yazdan P
Am J Dermatopathol 2018 Jul;40(7):498-501. doi: 10.1097/DAD.0000000000001075. PMID: 29293128
Faivre C, Villani AP, Aubin F, Lipsker D, Bottaro M, Cohen JD, Durupt F, Jeudy G, Sbidian E, Toussirot E, Badot V, Barbarot S, Debarbieux S, Delaporte E, Goegebeur G, Morel J, Nassif A, Duru G, Jullien D; French Society of Dermatology and Club Rheumatisms and Inflammation
J Am Acad Dermatol 2016 Jun;74(6):1153-9. Epub 2016 Mar 8 doi: 10.1016/j.jaad.2016.01.018. PMID: 26965410
Paoletti V, Mammarella A, Basili S, Paradiso M, Di Franco M, De Matteis A, Musca A
Panminerva Med 2002 Dec;44(4):349-52. PMID: 12434117
Reunala T, Collin P
Br J Dermatol 1997 Mar;136(3):315-8. PMID: 9115907

Diagnosis

Schneeweiss MC, Mostaghimi A, Chiuve S, Schneeweiss S, Anand P, Schoder K, Oduol T, Huisingh C, Lin KJ
Pharmacoepidemiol Drug Saf 2024 Apr;33(4):e5782. doi: 10.1002/pds.5782. PMID: 38566351
Doytcheva K, Tan T, Guitart J, Gerami P, Yazdan P
Am J Dermatopathol 2018 Jul;40(7):498-501. doi: 10.1097/DAD.0000000000001075. PMID: 29293128
Reunala T, Collin P
Br J Dermatol 1997 Mar;136(3):315-8. PMID: 9115907

Therapy

Schneeweiss MC, Mostaghimi A, Chiuve S, Schneeweiss S, Anand P, Schoder K, Oduol T, Huisingh C, Lin KJ
Pharmacoepidemiol Drug Saf 2024 Apr;33(4):e5782. doi: 10.1002/pds.5782. PMID: 38566351
Faivre C, Villani AP, Aubin F, Lipsker D, Bottaro M, Cohen JD, Durupt F, Jeudy G, Sbidian E, Toussirot E, Badot V, Barbarot S, Debarbieux S, Delaporte E, Goegebeur G, Morel J, Nassif A, Duru G, Jullien D; French Society of Dermatology and Club Rheumatisms and Inflammation
J Am Acad Dermatol 2016 Jun;74(6):1153-9. Epub 2016 Mar 8 doi: 10.1016/j.jaad.2016.01.018. PMID: 26965410
Temesvári E, González R, Marschalkó M, Horváth A
Contact Dermatitis 2004 Jun;50(6):381-2. doi: 10.1111/j.0105-1873.2004.0350h.x. PMID: 15274737

Prognosis

Schneeweiss MC, Mostaghimi A, Chiuve S, Schneeweiss S, Anand P, Schoder K, Oduol T, Huisingh C, Lin KJ
Pharmacoepidemiol Drug Saf 2024 Apr;33(4):e5782. doi: 10.1002/pds.5782. PMID: 38566351
Patel KR, Lee HH, Rastogi S, Singam V, Vakharia PP, Silverberg JI
Dermatology 2019;235(4):276-286. Epub 2019 Jun 4 doi: 10.1159/000499564. PMID: 31163441

Clinical prediction guides

Schneeweiss MC, Mostaghimi A, Chiuve S, Schneeweiss S, Anand P, Schoder K, Oduol T, Huisingh C, Lin KJ
Pharmacoepidemiol Drug Saf 2024 Apr;33(4):e5782. doi: 10.1002/pds.5782. PMID: 38566351
Faivre C, Villani AP, Aubin F, Lipsker D, Bottaro M, Cohen JD, Durupt F, Jeudy G, Sbidian E, Toussirot E, Badot V, Barbarot S, Debarbieux S, Delaporte E, Goegebeur G, Morel J, Nassif A, Duru G, Jullien D; French Society of Dermatology and Club Rheumatisms and Inflammation
J Am Acad Dermatol 2016 Jun;74(6):1153-9. Epub 2016 Mar 8 doi: 10.1016/j.jaad.2016.01.018. PMID: 26965410

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...